Effects of systemically administered abaloparatide, an osteoanabolic PTHrP analog, as an adjuvant therapy for spinal fusion in rats

by Heike Arlt, Tatiana Besschetnova, Michael S. Ominsky, Douglas C. Fredericks, Beate Lanske
Published 2021-03-01

Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice

by Heike Arlt, Tara Mullarkey, Dorothy Hu, Roland Baron, Michael S. Ominsky, Bruce Mitlak, Beate Lanske, Tatiana Besschetnova
Published 2020-12-01

Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors

by Hitisha K. Patel, Nianjun Tao, Kyung-Min Lee, Mariela Huerta, Heike Arlt, Tara Mullarkey, Steven Troy, Carlos L. Arteaga, Teeru Bihani
Published 2019-12-01

Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.

by Michael Lampa, Heike Arlt, Timothy He, Beatriz Ospina, Jason Reeves, Bailin Zhang, Joshua Murtie, Gejing Deng, Claude Barberis, Dietmar Hoffmann, Hong Cheng, Jack Pollard, Christopher Winter, Victoria Richon, Carlos Garcia-Escheverria, Francisco Adrian, Dmitri Wiederschain, Lakshmi Srinivasan
Published 2017-01-01